Rugen Therapeutics
Rugen Therapeutics is a biotech company in Boston, United States, founded in 2013. It has raised $46.5M across 2 rounds, most recently a $38.0M Series A in June 2020.
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2013
- Total Funding
- $46.5M
- Last Round
- $38.0M Series AJun 2020
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Biotech company developing first-in-class small-molecule drugs for CNS disorders including autism, OCD, and treatment-resistant depression.
Summary
It lists 1–10 employees. It has raised $46.5M in total across 2 rounds, most recently a $38.0M Series A round in Jun 2020. Investors include F-Prime Capital and Boehringer Ingelheim Venture Fund.
Funding History
Jun 2020
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rugen-therapeutics"><img src="https://indexed.vc/api/badge/company/rugen-therapeutics" alt="Rugen Therapeutics on Indexed.vc" width="260" height="76" /></a>